Cargando…

Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies

OBJECTIVES: In patients with systemic autoimmune rheumatic disorders (SARDs), vaccination with SARS-CoV-2 mRNA vaccines has been proposed. The aim of this study is to evaluate the immune response elicited by vaccination with mRNA vaccine, testing IgM, IgA and IgG antibodies to SARS-CoV-2 receptor-bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tani, Chiara, Pratesi, Federico, Talarico, Rosaria, Cardelli, Chiara, Caruso, Teresita, Di Cianni, Federica, Laurino, Elenia, Italiano, Nazzareno, Moretti, Michele, Manca, Maria Laura, Migliorini, Paola, Mosca, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655339/ https://www.ncbi.nlm.nih.gov/pubmed/34880126 http://dx.doi.org/10.1136/rmdopen-2021-001914

Ejemplares similares

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
por: Caruso, Teresita, et al.
Publicado: (2023)

Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
por: Caruso, Teresita, et al.
Publicado: (2023)

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers
por: Pratesi, Federico, et al.
Publicado: (2021)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Sleep quality in Behçet’s disease: a systematic literature review
por: Italiano, N., et al.
Publicado: (2022)

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
por: Carnell, George W., et al.
Publicado: (2023)

Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections
por: Minosse, Claudia, et al.
Publicado: (2021)

Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream
por: Zucchi, Dina, et al.
Publicado: (2023)

Avidity of anti-phospholipid antibodies in relation to their levels
por: FIALOVÁ, LENKA, et al.
Publicado: (2020)

2356. Close correlation of RBD with Live Viral Neutralising Capacity Across Variants and Time Supports Use of RBD Thresholds to Predict Protective Host Immunity
por: Kenny, Grace, et al.
Publicado: (2023)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
por: Sasson, S. C., et al.
Publicado: (2021)

Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
por: Brighty, David W, et al.
Publicado: (2014)

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021)

Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
por: Talarico, Rosaria, et al.
Publicado: (2020)

Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
por: Manuylov, Victor, et al.
Publicado: (2022)

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
por: Gaspar, Emanuelle Baldo, et al.
Publicado: (2021)

Post-recovery enhancement of anti-variant neutralisation after severe COVID-19
por: Lu, Yingying, et al.
Publicado: (2022)

Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience
por: Baratè, Claudia, et al.
Publicado: (2022)

Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19
por: Servian, Carolina do Prado, et al.
Publicado: (2023)

Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients with Multiple Sclerosis
por: Fialová, Lenka, et al.
Publicado: (2011)

Endotoxin-neutralising effect and anti-inflammatory properites of tobramycin and ceftazidime in porcine endotoxic shock
por: Goscinski, G, et al.
Publicado: (2003)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus
por: Virdis, Agostino, et al.
Publicado: (2015)

Gender differences in SLE: report from a cohort of 417 Caucasian patients
por: Trentin, Francesca, et al.
Publicado: (2023)

Structural basis for endotoxin neutralisation and anti-inflammatory activity of thrombin-derived C-terminal peptides
por: Saravanan, Rathi, et al.
Publicado: (2018)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

IN VITRO-INITIATED SECONDARY ANTI-HAPTEN RESPONSE : II. INCREASING CELL AVIDITY FOR ANTIGEN
por: Bullock, Wesley W., et al.
Publicado: (1970)

Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01(E) in Young Children
por: Olotu, Ally, et al.
Publicado: (2014)

Anti-Toxoplasma gondii IgG avidity testing is necessary for diagnosis of acute toxoplasmosis
por: Nasir, Idris-Abdullahi, et al.
Publicado: (2017)

Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda
por: Ssewanyana, Isaac, et al.
Publicado: (2017)

Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity
por: Doherty, Leana, et al.
Publicado: (2017)

Urea dilution of serum for reproducible anti-HSV1 IgG avidity index
por: Olsson, Jan, et al.
Publicado: (2019)

Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cells
por: Sugiyarto, Gessa, et al.
Publicado: (2020)

Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
por: Obeng, Eugene M., et al.
Publicado: (2022)

Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors
por: Bindoli, Sara, et al.
Publicado: (2023)

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA
por: Schmiedeberg, Kristin, et al.
Publicado: (2022)

Avid Editing
por: Kauffmann, Sam, et al.
Publicado: (2017)

An Avid Imitator
por: Farmakiotis, Dimitrios, et al.
Publicado: (2016)

Anti-glutathione S-transferase omega 1-1 (GSTO1-1) antibodies are increased during acute and chronic inflammation in humans
por: Piaggi, Simona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fjcep0lqaf4nc2kn2bjb6jld5d